NCT00036608已完成3 期
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine
Bristol-Myers Squibb39 个研究点 分布在 1 个国家开始时间: 2002年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 39
研究概览
简要总结
The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female subjects =/> 16 years of age (or minimum age required in a given country) with history of HBeAg-positive chronic hepatitis B infection;
- •Incomplete response to current lamivudine therapy;
- •HBeAg-positive;
- •Absence of coinfection with human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis D virus (HDV);
- •Absence of other forms of liver disease e.g., alcoholic, autoimmune, biliary disease.
排除标准
- 未提供
研究者
研究点 (39)
Loading locations...
相似试验
已完成
3 期
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenChronic Hepatitis BNCT00035789Bristol-Myers Squibb
已完成
3 期
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenChronic Hepatitis BNCT00035633Bristol-Myers Squibb
终止
4 期
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationChronic Hepatitis BNCT01627223Taichung Veterans General Hospital17
终止
3 期
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B InfectionChronic Hepatitis BNCT00605384Bristol-Myers Squibb4
进行中（未招募）
3 期
Entecavir to TAF SwitchHepatitis BNCT03489239Thomas Jefferson University27